BALTIMORE (WJZ) — Preliminary data from the Pfizer, BioNTech Phase 1 mRNA COVID-19 vaccine trials are showing promise, according to the University of Maryland School of Medicine.
Trials have been conducted at the University of Maryland’s Center for Vaccine Development.
- TIMELINE: Coronavirus In Maryland, Tracking The Spread
- Latest coronavirus stories from WJZ
- Latest CDC Guidelines
Phase III efficacy trials for COVID-19 vaccines are expected to begin in the area soon, according to the University of Maryland’s Center for Vaccine Development.